Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Living with a chronic pain condition can make everyday tasks more challenging. For some people in Southern Utah dealing with ...

Six months of chemotherapy in low-risk stage 3 colorectal cancer patients increases neuropathy compared to three months. IDEA ...

Are you feeling frustrated getting pill after pill only to find that there is little to no relief. Schedule a consultation with Dr. Stephanie Scott with Salt Lake Acupuncture Clinic in Sandy, so she ...

Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.

Will the neuropathy ever go away ... she has about a 50% chance of recovery during the next year. I don’t know of any ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...

There's a potential new treatment for people who develop shingles that spread to the eye. Doctors say about 8% of shingles ...

When you think of the YMCA, you might think of working out. But the "Y's" Thriver's Club is about more than making your ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...